The MyMeds&Me team includes experts from pharmacovigilance, clinical and software development. Our experts will share their latest thinking on our blog. Planned topics include, practical impact on transformation of your drug safety, operations and technology implementation advice. 

Thank you for reading!

11 January 2016

Making the Transition from Passive to Active Pharmacovigilance

In preparation for my presentation at Pharmadanmark, I have been documenting the growing pressures on life sciences and the rapidly developing Pharmacovigilance landscape. I believe there is an imperative need to move from manual to automated PV processes to respond to these changes and to deliver higher levels of compliance & improved quality.
By Dr Andrew Rut
31 March 2015

Debating the Future of Spontaneous Reporting

At first glance, receiving an invitation to mark an important MHRA milestone with esteemed industry colleagues in Edinburgh sounded like an excellent opportunity to catch up with pharmacovigilance and regulatory colleagues. Edinburgh is just a short flight from London and the city is steeped in history, culture and science. How could I say no?
By Dr Andrew Rut
  • 1

Fascinating panel session on FDA REMS at PVlegal Biannual this week in NJ. MyMeds&ME thanks @SidleyLifeSci for hosting a superb meeting.

Pvlegal Biannual meet today - Join MyMed&Me's Andrew Rut discussing 10 years of risk evaluation and mitigation in #pharmacovigilance now

We will be at NavitasLS/pvlegal Biannual tomorrow. Join us to find out more about Reportum solution for PV. Agenda:

Keep informed

For expert insight and updates from the MyMeds&Me team.

We respect your privacy and we will only use your email address for newsletters and company updates